Descovy (emtricitabine/tenofovir alafenamide fumarate) — Point32Health
HIV-1 infection treatment
Preferred products
- emtricitabine/tenofovir disoproxil fumarate 200-300 mg (generic Truvada)
Initial criteria
- The patient has a documented diagnosis of HIV-1 infection AND is using Descovy as part of an antiretroviral treatment (ART) regimen OR BOTH of the following:
- Descovy 200 mg/25 mg is being requested for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sexual acquisition
- The patient has tried OR has a contraindication to OR clinical intolerance to emtricitabine/tenofovir disoproxil fumarate 200-300 mg (generic Truvada)
Approval duration
life of plan